KDM2B-IN-4
Product Specifications
UNSPSC Description
KDM2B-IN-4 is a histone demethylase KDM2B inhibitor extracted from patent WO2016112284A1, compound 182b. KDM2B-IN-4 can be used for the research of cancer[1].
Target Antigen
Histone Demethylase
Type
Reference compound
Related Pathways
Epigenetics
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kdm2b-in-4.html
Smiles
N#CCC1=C(OC)C=CC2=C1C=CC(C([C@@H]3CN(C4CCC4)CC[C@@H]3C)=O)=C2
Molecular Weight
376.49
References & Citations
[1]Albrecht BK, et, al. (piperidin-3-yl)(naphthalen-2-yl)methanone derivatives and related compounds as inhibitors of the histone demethylase kdm2b for the treatment of cancer. WO2016112284A1.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-139601/KDM2B-IN-4-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-139601/KDM2B-IN-4-SDS-MedChemExpress.pdf
CAS Number
1966933-85-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Polyclonal IFN-alpha H2/IFNA14 Antibody [HRP]](https://cdn.genprice.uk/genprice/genprice4.png)
MBS6158551-01 0.1 mL
KRIT1 (Krev Interaction Trapped Protein 1, Krev Interaction Trapped 1, Cerebral Cavernous Malformations 1 Protein, CCM1) (PE)
Ask
View Details MBS6158551-02 5x 0.1 mL
KRIT1 (Krev Interaction Trapped Protein 1, Krev Interaction Trapped 1, Cerebral Cavernous Malformations 1 Protein, CCM1) (PE)
Ask
View Details